Globus Medical Inc. (GMED) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Globus Medical Inc. (GMED:NYSE), powered by AI.

Current Price
$77.52
P/E Ratio
19.5
Market Cap
10.5B
Sector
Healthcare
What is the Globus Medical Inc. stock price forecast?

Globus Medical Inc. is currently trading at $77.52. View real-time AI analysis on Alpha Lenz.

What is Globus Medical Inc. insider trading activity?

View the latest insider trading data for Globus Medical Inc. on Alpha Lenz.

What is Globus Medical Inc.'s P/E ratio?

Globus Medical Inc.'s P/E ratio is 19.5.

Globus Medical Inc.

NYSE · GMED
$77.52+0.20(+0.26%)Pre-marketNYSE regular session 09:30–16:00 ET
Ask about Globus Medical Inc.'s future dividend policy...
Alpha Chat Insight

Globus Medical Inc. trades at a P/E of 19.5 (fair value) with solid ROE of 12.3%. 3Y revenue CAGR of 42.2% highlights clear growth momentum.

Ask for details

Company Overview

Globus Medical Inc. is a leading medical device company known for its innovation and advancement in musculoskeletal solutions. The company specializes in developing products that address a broad spectrum of orthopedic issues, with a strong emphasis on spinal surgeries. Its extensive portfolio comprises a variety of implants and surgical tools designed to enhance procedures related to the spine, orthopedics, and trauma. By constantly pushing the boundaries of medical technology, Globus Medical Inc. plays a pivotal role in improving surgical outcomes and patient recovery rates. Headquartered in Audubon, Pennsylvania, the company serves a global market, impacting sectors spanning hospitals, clinics, and private practices. Its commitment to research and development drives significant growth and ongoing improvements in healthcare delivery. With a robust network of distribution and a reputation for quality and reliability, Globus Medical Inc. holds a distinguished place within the medical devices industry, contributing to advancing the standards of patient care worldwide. The company’s influence extends across diverse regions, making it a significant player in the global medical device market.

CEOMr. Keith W. Pfeil
SectorHealthcare
IndustryMedical Devices
Employees5,300

Company Statistics

FY 2025

Profile

$10.48BMarket Cap
$2.94BRevenue
0.00Shares Out
5,300Employees

Margins

67.41%Gross
25.75%EBITDA
18.28%Operating
20.59%Pre-Tax
18.30%Net

Valuation

19.49P/E
2.29P/B
3.57EV/Sales
13.31EV/EBITDA
18.10P/FCF

Growth (CAGR)

42.17%Rev 3Yr
30.08%Rev 5Yr
31.50%Op Inc 3Yr
36.00%Op Inc 5Yr
41.42%Net Inc 3Yr
39.37%Net Inc 5Yr

Returns

10.19%ROA
12.29%ROE
10.18%ROIC

Financial Health

$526.16MCash & Cash Equivalents
$203.35MNet Debt
15.95%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Globus Medical Inc. (ticker: GMED) is a company listed on NYSE in the Healthcare sector (Medical Devices). It has approximately 5,300 employees. Market cap is $10.5B.

The current price is $77.52 with a P/E ratio of 19.49x and P/B of 2.29x.

ROE is 12.29% and operating margin is 18.28%. Annual revenue is $2.9B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Globus Medical Inc. (GMED) Stock Forecast 2026 $77.52 — Price, Financials & Analyst Targets | Alpha Lenz